Claudia Ivette Rivas-Ortiz

Dr. Claudia Ivette Rivas-Ortiz

Profesor Asociado Facultad de Ciencias, UNAM
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GMGabriela Molina
Gabriela Molina
CRClaudia Ivette Rivas-Ortiz
Claudia Ivette Rivas-Ortiz
ASAlejandro Schcolnik-Cabrera
Alejandro Schcolnik-Cabrera
ARAntonia Isabel Castillo Rodal
Antonia Isabel Castillo Rodal
YVYolanda López- Vidal
Yolanda López- Vidal
Currently, the only available vaccine against tuberculosis is Mycobacterium bovis Bacille Calmette-Guérin (BCG). Pulmonary tuberculosis protection provided by the vaccine varies depending on the strain, the patient’s age and the evaluated population. Although the adaptive immune responses induced by different BCG strains have been widely studied, little conclusive data is available regarding innate immune responses, especially in macrophages. Here, we aimed to characterize the innate immune responses of human THP-1-derived macrophages at the transcriptional level following a challenge with either the BCG Mexico (M.BCG) or Phipps (P.BCG) strains. After a brief in vitro characterization of the bacterial strains and the innate immune responses, including nitric oxide production and cytokine profiles, we analyzed the mRNA expression patterns and performed pathway enrichment analysis using RNA microarrays. Our results showed that multiple biological processes were enriched, especially those associated with innate inflammatory and antimicrobial responses, including tumor necrosis factor (TNF)-α, type I interferon (IFN-I) and IFN-γ. However, four DEGs were identified in macrophages infected with M.BCG compared to P. BCG. These findings indicated the proinflammatory stimulation of macrophages induced by both BCG strains, at the cytokine level and in terms of gene expression, suggesting a differential expression pattern of innate immune transcripts depending on the mycobacterial strain.

20 January 2022 in Processes
Verified
Journal Article
Open access
PDF file
CRClaudia Ivette Rivas-Ortiz
Claudia Ivette Rivas-Ortiz
SMStephanie Euridice Morales-Guerrero
Stephanie Euridice Morales-Guerrero
SPSergio Ponce-De-León-Rosales
Sergio Ponce-De-León-Rosales
AGArmando Gamboa-Domínguez
Armando Gamboa-Domínguez
Claudia Rangel-EscareñoClaudia Rangel-Escareño
Claudia Rangel-Escareño
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
Chronic Helicobacter pylori infection produces several lesions in the human stomach, which can progress to chronic atrophic gastritis and gastric cancer. To date, there is very little information on gene expression in chronic atrophic gastritis and its relationship with progression to gastric cancer. In this study, we performed a gene expression analysis during chronic atrophic gastritis in order to identify possible biomarkers that allow an early diagnosis of gastric cancer. We studied biopsies from patients with chronic atrophic gastritis and gastric cancer. The biopsies were analyzed by a gene expression microarray and corroborated by qPCR and validated through immunohistochemistry. Our results revealed that gene expression profiles in patients with chronic atrophic gastritis showed molecular changes of the gastric mucosa, leading to gastric cancer. The gene expression profiles of CLDN1, CLDN7, OLFM4, C-MYC and MMP9 were more notable from the chronic atrophic gastritis. The gene expression patterns observed in this study allowed the identification of CLDN1 and MMP9 proteins as promising biomarkers of early stages of gastric cancer development.